|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 571.4 INR | -1.83% |
|
-7.12% | +13.26% |
| 05-14 | GRIFOLS SHARES DOWN 4.8% AFTER GOTHAM CITY RESEARCH ISSUES REPOR… | RE |
| 05-13 | Aarti Pharmalabs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
Aarti Pharmalabs Limited reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was INR 14,601.71 million. Revenue was INR 14,617.44 million.
Net income was INR 1,506.17 million. Basic earnings per share from continuing operations was INR 16.62. Diluted earnings per share from continuing operations was INR 16.62.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.26% | 635M | |
| +37.47% | 727B | |
| -7.87% | 354B | |
| +15.58% | 328B | |
| -0.38% | 277B | |
| +13.47% | 243B | |
| +7.35% | 205B | |
| -6.42% | 203B | |
| +3.85% | 164B | |
| -2.10% | 164B |
AARTI PHARMALABS LIMITED 
